Collegium Pharmaceutical Inc (COLL)

Return on assets (ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	48,155	9,016	-11,161	-29,359	-25,002	-42,837	-35,248	42,786	71,517	103,509	106,749	41,964	26,752	17,593	198	-12,572	-22,722	-11,435	-21,828	-30,176
Total assets	US$ in thousands	1,143,310	1,177,580	1,213,910	1,214,300	1,174,130	1,200,940	1,245,570	1,246,140	692,077	741,803	713,735	646,065	643,841	643,843	646,870	634,793	306,302	303,978	301,581	294,362
ROA		4.21%	0.77%	-0.92%	-2.42%	-2.13%	-3.57%	-2.83%	3.43%	10.33%	13.95%	14.96%	6.50%	4.16%	2.73%	0.03%	-1.98%	-7.42%	-3.76%	-7.24%	-10.25%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $48,155K ÷ $1,143,310K
= 4.21%

Collegium Pharmaceutical Inc's return on assets (ROA) has shown significant fluctuation over the past eight quarters. In Q4 2023, the ROA stands at 4.21%, indicating an improvement from the previous quarter. Prior to this, there was a notable increase from Q2 2023 to Q3 2023, where the ROA rose from -0.92% to 0.77%.

However, it is crucial to note that Collegium Pharmaceutical Inc experienced negative ROA values in several quarters, including Q1 2023, Q4 2022, Q3 2022, and Q2 2022. The lowest ROA was seen in Q1 2023 at -2.42%.

Overall, while Collegium Pharmaceutical Inc has demonstrated some improvement in its ROA in recent quarters, it is essential to further analyze the company's financial performance and the factors contributing to these fluctuations to assess its operational efficiency and profitability.